FinancialContent is the trusted provider of stock market information to the media industry.
September 02, 2013 at 18:32 PM EDT
Research and Markets: Tuberculosis - Pipeline Review, H2 2013 Reviews Key Players Involved in the Therapeutic Development for Tuberculosis

Research and Markets (http://www.researchandmarkets.com/research/fg4ns5/tuberculosis) has announced the addition of the "Tuberculosis - Pipeline Review, H2 2013" report to their offering.

Global Markets Direct's, 'Tuberculosis - Pipeline Review, H2 2013', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Tuberculosis, complete with latest updates, and special features on late-stage and discontinued projects. Tuberculosis - Pipeline Review, Half Year is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team.

Scope

- A snapshot of the global therapeutic scenario for Tuberculosis.

- A review of the Tuberculosis products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.

- Coverage of products based on various stages of development ranging from discovery till registration stages.

- A feature on pipeline projects on the basis of monotherapy and combined therapeutics.

- Coverage of the Tuberculosis pipeline on the basis of route of administration and molecule type.

- Key discontinued pipeline projects.

- Latest news and deals relating to the products.

Companies Mentioned:

  • AVI BioPharma Inc.
  • Achillion Pharmaceuticals, Inc.
  • Advinus Therapeutics Pvt. Ltd.
  • Archivel Farma S.L.
  • AstraZeneca PLC
  • B&C Biopharm
  • BT PHARMA
  • Canopus BioPharma Incorporated
  • Chimerix, Inc.
  • Crucell N.V.
  • Eli Lilly and Company
  • Ensoltek Co., Ltd.
  • EpiVax, Inc.
  • GlaxoSmithKline Inc.
  • GlaxoSmithKline plc
  • Hollis-Eden Pharmaceuticals, Inc.
  • ISA Pharmaceuticals B.V.
  • Immune Network Research Ltd.
  • ImmunoBiology Limited
  • ImmunoVaccine Technologies Inc.
  • Johnson & Johnson
  • Lipotek Pty Ltd
  • Medisyn Technologies, Inc.
  • MicuRx Pharmaceuticals, Inc.
  • Mondobiotech Holding AG
  • NeED Pharma s.r.l.
  • Okairos
  • Pharminox Limited
  • Piramal Healthcare Limited
  • Pt. Bio Farma
  • Recipharm AB
  • Sanofi-Aventis
  • Sequella, Inc.
  • Snowdon Inc.
  • Statens Serum Institut
  • Summit Corporation plc
  • TVAX Biomedical, LLC
  • Transgene SA
  • Vakzine Projekt Management GmbH
  • Vertex Pharmaceuticals Incorporated
  • Vichem Chemie Research Ltd.

For more information visit http://www.researchandmarkets.com/research/fg4ns5/tuberculosis

About Research and Markets

Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Contacts:

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Infectious Diseases
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here
   
Financial Widgets

Display market data, financial news or stock quotes - Learn More

Advertising Network

Advertise on FinancialContent's huge network - Learn More

Web Services

Power your internet and wireless applications - Learn More